Healthcare · Antimicrobial resistance burden

Antimicrobial resistance burden in USA in 2026

The antimicrobial resistance burden in the United States is estimated at 15.5 DALY/100k, ranking 38-th among 197 countries. Despite a well-developed hospital infection control system and national antibiotic stewardship programs, pathogen resistance remains a serious challenge. Methicillin-resistant Staphylococcus aureus (MRSA) and resistant Enterobacteriaceae spreading in intensive care units are of particular concern. Agriculture, where antibiotics are used for growth promotion in livestock, also contributes to the problem.

Data for 2026 · unit: DALY/100k
Position

USA world ranking

#38 / 197

Country position on the scale from last to first place for this indicator.

US
#38
#197#1
Trend

Change over time

Change in indicator over the available period.

5.2
2000
18.0
2010
16.0
2020
15.5
2026

Values — DALY/100k

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Antimicrobial resistance burden in USA — how much?
Based on 2026 data — 15.5 DALY/100k. This is rank #38 out of 197 countries.
What is USA's rank by Antimicrobial resistance burden?
USA ranks #38 out of 197 countries in the world ranking by «Antimicrobial resistance burden».
How has Antimicrobial resistance burden changed in USA?
Over the available period the indicator changed from 5.2 to 15.5 DALY/100k.